Management of early nephropathy in diabetic patients.
Diabetic patients go through several stages of renal disease, moving from normo- to micro- to macroalbuminuria. Good metabolic control can prevent or postpone the development of microalbuminuria, the earliest sign of diabetic renal disease. Thus, efforts should focus on obtaining the best possible control before the onset of microalbuninuria. In patients with microalbuminuria, blood pressure starts to increase, and early antihypertensive treatment becomes important. Good glycemic control may be difficult to achieve. With overt nephropathy, defined as clinical proteinuria, a relentless decline in glomerular filtration rate (GFR) occurs unless patients are carefully treated with antihypertensive agents. Protein restriction may also be necessary, but a clear beneficial effect of optimized diabetes care is difficult to document. Early screening is recommended, with an emphasis on testing for albuminuria, including microalbuminuria, along with careful control of blood pressure.
Mogensen
C E
CE
Medical Department M, Aarhus Kommunehospital, University Hospitals, Denmark.
D000419:Albuminuria / Q000175:diagnosis / Q000628:therapy; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007677:Kidney Function Tests
D001786:Blood Glucose